CA1335816C - 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives - Google Patents

4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives

Info

Publication number
CA1335816C
CA1335816C CA000590484A CA590484A CA1335816C CA 1335816 C CA1335816 C CA 1335816C CA 000590484 A CA000590484 A CA 000590484A CA 590484 A CA590484 A CA 590484A CA 1335816 C CA1335816 C CA 1335816C
Authority
CA
Canada
Prior art keywords
formula
compound
pyridyl
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000590484A
Other languages
English (en)
French (fr)
Inventor
Michael James Smithers
Andrew George Brewster
Reginald Jessup
George Robert Brown
Alan Wellington Faull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888803516A external-priority patent/GB8803516D0/en
Priority claimed from GB888824666A external-priority patent/GB8824666D0/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA1335816C publication Critical patent/CA1335816C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000590484A 1988-02-16 1989-02-08 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives Expired - Fee Related CA1335816C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888803516A GB8803516D0 (en) 1988-02-16 1988-02-16 Heterocyclic compounds
GB8803516 1988-02-16
GB888824666A GB8824666D0 (en) 1988-10-21 1988-10-21 Pyridine derivatives
GB8824666.5 1988-10-21

Publications (1)

Publication Number Publication Date
CA1335816C true CA1335816C (en) 1995-06-06

Family

ID=26293498

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000590484A Expired - Fee Related CA1335816C (en) 1988-02-16 1989-02-08 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives

Country Status (24)

Country Link
US (1) US5166213A (xx)
EP (1) EP0329360B1 (xx)
JP (1) JP2812697B2 (xx)
KR (1) KR0145725B1 (xx)
CN (1) CN1040753C (xx)
AR (1) AR246965A1 (xx)
AT (1) ATE109478T1 (xx)
AU (1) AU626534B2 (xx)
CA (1) CA1335816C (xx)
DE (1) DE68917170T2 (xx)
DK (1) DK66989A (xx)
ES (1) ES2057104T3 (xx)
FI (1) FI93216C (xx)
GB (1) GB8901201D0 (xx)
HU (1) HU209700B (xx)
IE (1) IE63825B1 (xx)
IL (1) IL89214A (xx)
MY (1) MY103699A (xx)
NO (1) NO172491C (xx)
NZ (1) NZ227880A (xx)
PH (1) PH26227A (xx)
PL (1) PL158201B1 (xx)
PT (1) PT89703B (xx)
ZW (1) ZW1789A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
RU2449999C2 (ru) * 2006-01-18 2012-05-10 Эвольва Са Модуляторы ppar
MX2009007670A (es) * 2007-01-18 2011-11-18 Evolva Sa 1,3-dioxanos sustituidos utiles como moduladores de paar.
WO2008089463A2 (en) * 2007-01-18 2008-07-24 Evolva Sa Substituted 1,3-dioxanes and their uses

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0062238B1 (de) * 1981-03-30 1985-01-30 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1,3-Dioxolan-Derivate, Herstellung dieser Verbindungen, fungizide Mittel, die diese Verbindungen als Wirkstoffe enthalten sowie Verwendung solcher Verbindungen bzw. Mittel zur Bekämpfung von Fungi in der Landwirtschaft und im Gartenbau
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8330099D0 (en) * 1983-11-11 1983-12-21 Ici Plc Cycloalkane derivatives
US4554011A (en) * 1984-08-24 1985-11-19 Chevron Research Company Herbicidal 2S-(2β,4β,5β)-5-Arylmethoxy-4-substituted 2-alkyl-1,3-dioxane derivatives
GB8511891D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenoic acids
GB8511892D0 (en) * 1985-05-10 1985-06-19 Ici Plc Fluoralkane derivatives
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
GB8511894D0 (en) * 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
ES2017633B3 (es) * 1985-11-12 1991-03-01 Ici Plc Amido derivados.
GB8531892D0 (en) * 1985-12-30 1986-02-05 Ici Plc Carboxylic acids
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives

Also Published As

Publication number Publication date
ES2057104T3 (es) 1994-10-16
HU209700B (en) 1994-10-28
CN1035115A (zh) 1989-08-30
IL89214A (en) 1994-01-25
DE68917170D1 (de) 1994-09-08
JP2812697B2 (ja) 1998-10-22
PT89703B (pt) 1994-04-29
PT89703A (pt) 1989-10-04
GB8901201D0 (en) 1989-03-15
DK66989D0 (da) 1989-02-13
AU2990889A (en) 1989-08-17
EP0329360B1 (en) 1994-08-03
IE63825B1 (en) 1995-06-14
AU626534B2 (en) 1992-08-06
KR0145725B1 (ko) 1998-08-17
EP0329360A2 (en) 1989-08-23
NO890607D0 (no) 1989-02-13
CN1040753C (zh) 1998-11-18
FI93216C (fi) 1995-03-10
EP0329360A3 (en) 1990-09-05
MY103699A (en) 1993-08-28
FI890678A0 (fi) 1989-02-13
KR890013005A (ko) 1989-09-20
DE68917170T2 (de) 1994-12-15
DK66989A (da) 1989-08-17
PH26227A (en) 1992-04-01
US5166213A (en) 1992-11-24
NO172491B (no) 1993-04-19
NO890607L (no) 1989-08-17
FI890678A (fi) 1989-08-17
AR246965A1 (es) 1994-10-31
NZ227880A (en) 1991-10-25
FI93216B (fi) 1994-11-30
IE890392L (en) 1989-08-16
ZW1789A1 (en) 1990-03-21
ATE109478T1 (de) 1994-08-15
HUT54143A (en) 1991-01-28
NO172491C (no) 1993-07-28
PL158201B1 (pl) 1992-08-31
JPH01249770A (ja) 1989-10-05

Similar Documents

Publication Publication Date Title
US5053415A (en) Pyridine derivatives
CA1335816C (en) 4-pyridyl-1,3-dioxan-5-ylalkenoic acid derivatives
US4895962A (en) 2,4-diphenyl-1,3-dioxanes
US4921866A (en) 1,3-dioxanes
US5401849A (en) 4-pyridyl-1,3-dioxane derivatives
US4908380A (en) Pharmaceutical compositions
KR100191763B1 (ko) 헤테로시클릭산
RU2040525C1 (ru) 1,3-дииоксаноновые производные алкеновой кислоты или их фармацевтически приемлемая соль
EP0228887B1 (en) Dioxane hexenoic acids

Legal Events

Date Code Title Description
MKLA Lapsed